Analyst report

A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from UBIOPRED Cohorts

01.09.2017 | SymphonyAI team

Asthma is a heterogeneous disease that responds only partially to
currently available therapies. Understanding heterogeneity in severe
asthma at the molecular level and identifying biomarkers characterizing…

Asthma is a heterogeneous disease that responds only partially to
currently available therapies. Understanding heterogeneity in severe
asthma at the molecular level and identifying biomarkers characterizing…Read more

Latest Insights

 
02.05.2025 Blog

KYC Software vs CDD: What’s the difference?

Financial Services Square Icon Svg
 
02.04.2025 Webinar

AI in Action: Practical Applications for Financial Crime Prevention in 2025

Financial Services Square Icon Svg
 
02.04.2025 Webinar

The Future of Sanctions Compliance Programs in the Post-2022 Era

Financial Services Square Icon Svg